Arca
Skip to content
Tools
Tools

PPAT: Amidophosphoribosyltransferase

Catalyzes the formation of phosphoribosylamine from phosphoribosylpyrophosphate (PRPP) and glutamine. .

  • Drugs that act on it: 2
  • Approved: 2
  • In phases 1 to 3: 0
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on PPAT, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 2

Approved2

  • Azathioprine
  • Mercaptopurine anhydrous

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        AzathioprineBoxed warningApprovedTherakosSmall moleculeInhibitorAmidophosphoribosyltransferase inhibitor62
        Mercaptopurine anhydrousApproved—Small moleculeInhibitorAmidophosphoribosyltransferase inhibitor0

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
        Efficacy of Rituximab for Remission Maintenance in Patients With Primary Angiitis of the Central Nervous System: an Open-label, Randomized, Controlled Trial Comparing Systematic Rituximab Infusions and AzathioprineAzathioprinePhase 2Not yet recruitingCentre Hospitalier St AnneOct 29, 2026
        Clinical Efficacy of Telitacicept in Sjögren's Disease With Interstitial Lung DiseaseAzathioprine—RecruitingPeking University People's HospitalSep 28, 2026
        The Primary Objective of the Trial is to Evaluate the Effect of the Addition of Belantamab Mafodotin to Standard of Care Therapy on the Titres of Serum Anti-dsDNA Antibodies in Patients With Previously Treated SLE.AzathioprinePhase 2Not yet recruitingMedical Association for the Study of Cancer Biology and TreatmentSep 28, 2026
        Rituximab With Corticosteroids Versus Corticosteroids Plus Azathioprine for Moderate-to-Severe Pemphigus VulgarisAzathioprineEarly phase 1Not yet recruitingKhyber Teaching HospitalAug 17, 2026
        CD38 mAb Induction + Azathioprine Maintenance for Chronic Active AMR in Kidney Transplant RecipientsAzathioprineNot applicableNot yet recruitingwujianyongJul 21, 2026
        Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed, Moderate-to-severe Crohn's DiseaseAzathioprinePhase 4Not yet recruitingUniversity Hospital Schleswig-HolsteinJun 22, 2026
        PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid ExposureAzathioprinePhase 2Not yet recruitingTherakos LLCJun 2, 2026
        Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell DiseaseAzathioprinePhase 2RecruitingSt. Jude Children's Research HospitalJun 1, 2026

        Diseases most associated with it

        Open Targets association score, 0 to 1; all associations

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2362992, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. Gene name, function (UniProt Q06203, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.